BIOMARIN PHARMACEUTICAL INC's ticker is and the CUSIP is 09061GAH4. A total of 63 filers reported holding BIOMARIN PHARMACEUTICAL INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,593,787 | +21.0% | 3,701,500 | +22.9% | 0.00% | 0.0% |
| Q2 2023 | $2,971,018 | -7.8% | 3,012,500 | -4.0% | 0.00% | 0.0% |
| Q1 2023 | $3,222,934 | -4.1% | 3,137,500 | -0.7% | 0.00% | 0.0% |
| Q4 2022 | $3,359,528 | +3.6% | 3,159,500 | -3.0% | 0.00% | 0.0% |
| Q3 2022 | $3,243,000 | -0.6% | 3,257,500 | -1.2% | 0.00% | 0.0% |
| Q2 2022 | $3,262,000 | -23.4% | 3,295,500 | -22.1% | 0.00% | 0.0% |
| Q1 2022 | $4,260,000 | +36.7% | 4,231,500 | +42.0% | 0.00% | 0.0% |
| Q4 2021 | $3,117,000 | -1.3% | 2,980,500 | -3.4% | 0.00% | 0.0% |
| Q3 2021 | $3,158,000 | -0.2% | 3,086,500 | +1.0% | 0.00% | 0.0% |
| Q2 2021 | $3,165,000 | -15.4% | 3,054,500 | -17.4% | 0.00% | 0.0% |
| Q1 2021 | $3,743,000 | -10.9% | 3,699,500 | -5.5% | 0.00% | 0.0% |
| Q4 2020 | $4,200,000 | +100.2% | 3,914,500 | +95.8% | 0.00% | 0.0% |
| Q3 2020 | $2,098,000 | -19.9% | 1,999,000 | -6.7% | 0.00% | 0.0% |
| Q2 2020 | $2,618,000 | +13.3% | 2,142,000 | -2.8% | 0.00% | 0.0% |
| Q1 2020 | $2,310,000 | -8.0% | 2,204,000 | -7.2% | 0.00% | 0.0% |
| Q4 2019 | $2,511,000 | +3.2% | 2,376,000 | -4.0% | 0.00% | 0.0% |
| Q3 2019 | $2,434,000 | -8.8% | 2,476,000 | -3.7% | 0.00% | 0.0% |
| Q2 2019 | $2,668,000 | -3.2% | 2,570,000 | -4.6% | 0.00% | 0.0% |
| Q1 2019 | $2,756,000 | -26.7% | 2,694,000 | -28.8% | 0.00% | 0.0% |
| Q4 2018 | $3,761,000 | +27.4% | 3,782,000 | +36.5% | 0.00% | 0.0% |
| Q3 2018 | $2,952,000 | +31.8% | 2,770,000 | +17.1% | 0.00% | 0.0% |
| Q1 2018 | $2,239,000 | -59.4% | 2,365,000 | -57.1% | 0.00% | -50.0% |
| Q4 2017 | $5,520,000 | -51.9% | 5,513,000 | -51.0% | 0.00% | -50.0% |
| Q3 2017 | $11,467,000 | – | 11,250,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SHENKMAN CAPITAL MANAGEMENT INC | 30,138,000 | $29,510,000 | 3.72% |
| PFM Health Sciences, LP | 45,910,000 | $46,002,000 | 1.72% |
| Cheyne Capital Management (UK) LLP | 2,320,000 | $2,330,000 | 1.47% |
| ADVENT CAPITAL MANAGEMENT /DE/ | 41,077,000 | $41,277,000 | 0.66% |
| SSI INVESTMENT MANAGEMENT LLC | 9,071,000 | $9,068,000 | 0.50% |
| PALISADE CAPITAL MANAGEMENT, LP | 14,548,000 | $14,612,000 | 0.34% |
| RWC Asset Management LLP | 7,500,000 | $7,552,000 | 0.21% |
| KBC Group NV | 400,000 | $40,316,000 | 0.15% |
| PROSPECTOR PARTNERS LLC | 1,000,000 | $1,000,000 | 0.12% |
| MACKAY SHIELDS LLC | 11,822,000 | $11,816,000 | 0.10% |